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Abstract: Neural stem progenitor cells (NSPCs) from E13.5 mouse embryos can be maintained in
culture under proliferating conditions. Upon growth-factor removal, they may differentiate toward
either neuronal or glial phenotypes or both. Exosomes are small extracellular vesicles that are part of
the cell secretome; they may contain and deliver both proteins and genetic material and thus play
a role in cell–cell communication, guide axonal growth, modulate synaptic activity and regulate
peripheral nerve regeneration. In this work, we were interested in determining whether NSPCs
and their progeny can produce and secrete extracellular vesicles (EVs) and if their content can affect
cell differentiation. Our results indicate that cultured NSPCs produce and secrete EVs both under
proliferating conditions and after differentiation. Treatment of proliferating NSPCs with EVs derived
from differentiated NSPCs triggers cell differentiation in a dose-dependent manner, as demonstrated
by glial- and neuronal-marker expression.
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1. Introduction
During neural development, neural stem progenitor cells (NSPC) with a radial glia identity
produce neurons and glial cells in a spatiotemporally regulated manner. This complex process is driven
by both extrinsic and intrinsic signals that eventually determine the type and number of adult neural
cells [1,2]. Despite major progress in this field, the molecular mechanisms as well as the extrinsic and
intrinsic factors underlying lineage commitment in NSPCs remain only partially understood [3–5].
Cells displaying properties of neural stem progenitor cells have been isolated from different regions of
embryonic and adult murine central nervous systems and cultured in vitro in the presence of growth
factors that maintain NSPCs in a proliferative and undifferentiated state [6,7]; these cells retain some
radial glia characteristics and upon growth-factor deprivation, NSPCs can undergo differentiation and
give rise to a mixed population of neurons and glial cells [8].
The proper development and functionality of the nervous system relies both on the regulation
of intrinsic gene expression and on the intercellular communication among neural cells, which may
occur through different mechanisms, one of them being the release of different classes of vesicles into
extracellular space. Extracellular vesicles are spheroidal particles with different sizes, biogenesis and
release mechanisms; among them are exosomes, small vesicles (50–100 nm in diameter) generated
by exocytosis of endosomal organelles, multivesicular bodies, secreted by many cell types and
characterized by specific contents of lipids, proteins and nucleic acids strictly related to the cells of
origin [9,10]. Some of the membrane proteins and lipids found in exosomes are unique to these vesicles
and are commonly used as exosomal markers [11]. Comprehensive reviews of the role played by
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exosomes in a normal healthy nervous system, both during development and in adults have recently
been published [12–14]. It is now widely accepted that exosomes represent an important vehicle
of intercellular communication that allows parental cells to modify gene and protein expression in
recipient cells [10,13,15]. Extracellular vesicles may contribute to cell–cell communication during
embryonic development [16,17]. Several studies investigated exosome release from neuronal and
glial cells [12,14,18] and many efforts have been done to clarify their role in physiological and
pathological states [12,19]. It has recently been reported that exosomes derived from mesenchymal
stem cells promote neurogenesis and neurite remodeling [18]. The role that extracellular vesicles
may play in the mechanism of communication among stem cells has been pointed out in a recent
review, “Exchange of genetic information utilizing persistent bidirectional communication mediated
by stem cell EVs could regulate stemness, self-renewal and differentiation in stem cells and their
subpopulations” [11]. Regulation of neurogenesis by extracellular vesicles in neurogenic niches has
also been suggested [20–22].
The aim of our study is to determine whether neural progenitors and their progeny produce and
secrete EVs and if the latter play a role in the differentiation of neighboring target cells.
2. Results
2.1. Neural Stem Progenitor Cells Produce and Secrete EVs
To determine whether NSPCs actively produce and secrete EVs, we cultured NSPCs obtained from
13.5-day-old mouse embryos (see Section 4) in Expansion Medium containing both Epidermal Growth
Factor (EGF) and basic Fibroblast Growth Factor (bFGF). In these conditions, 85%–90% of cells are
immunopositive to an anti-nestin antibody, indicating that they maintain an undifferentiated phenotype.
We analyzed the culture medium of the proliferating NSPCs and we determined the protein
content of the EV fraction obtained as described in Materials and Methods: EVs are actively produced
and secreted by proliferating cells and their rate of secretion reaches a maximum between 36 and 48 h
in culture when cell confluence is at 60%–70% (Figure 1A).
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To ascertain whether the EV fraction from NSPCs cultured in Expansion Medium contained 
exosomes, we used exosomal markers such as HSP90, CD63, TSG101 and CD81 [23] and analyzed 
the EV fraction by western blot (Figure 1B), showing that it was enriched in some specific exosomal 
markers. We did not see any band for HSP90, probably because this specific marker is not present in 
extracellular vesicles produced by NSPCs. The blot for CD63 was overexposed in order to reveal the 
signal in the EV fraction. 
Secretion was also assessed in NSPC cultures differentiated by using three different protocols. 
NSPCs were: a) cultured in the presence of 10 ng/mL bFGF alone (bFGF differentiation medium), 
obtaining a mixed population of neurons and glial cells; b) cultured in the presence of 5% Fetal 
Figure 1. Extracellular vesicle (EV) secretion rate by proliferating neural stem progenitor cells (NSPCs)
and analysis with exosomal markers. (A) Protein concentration measured in the EV fraction of culture
medium of proliferating NSPC. Values are the mean of three independent experiments. (B) Western
blots of exosomal markers in extracts of proliferating cells and of EVs secreted in 48 h.
To ascertain whether the EV fraction from NSPCs cultured in Expansion Medium contained
exosomes, we used exosomal markers such as HSP90, CD63, TSG101 and CD81 [23] and analyzed
the EV fraction by western blot (Figure 1B), showing that it was enriched in some specific exosomal
markers. We did not see any band for HSP90, probably because this specific marker is not present in
extracellular vesicles produced by NSPCs. The blot for CD63 was overexposed in order to reveal the
signal in the EV fraction.
Secretion was also assessed in NSPC cultures differentiated by using three different protocols.
NSPCs were: (a) cultured in the presence of 10 ng/mL bFGF alone (bFGF differentiation medium),
obtaining a mixed population of neurons and glial cells; (b) cultured in the presence of 5% Fetal Bovine
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Serum (FBS differentiation medium); (c) cultured in the presence of 20 ng/mL Bone Morphogenetic
Protein 4 (BMP4 differentiation medium) [24]. In the last two culture conditions, enrichment in astroglial
cells was achieved. We decided to also use BMP4 as a differentiating agent because, as specified in
Section 2.2, its use may prevent the possibility that, even after FBS ultracentrifugation (see Section 4.2),
exosomes still present in FBS may have influenced our results.
NSPCs, maintained in the presence of bFGF differentiation medium, differentiated into cells
exhibiting an astrocytic and neuronal phenotype, as demonstrated by anti-Glial Fibrillary Acidic
Protein (GFAP) and anti-Microtubule Associated Protein (MAP2) labelling. In particular, after three
days in culture, 30%–35% cells were GFAP-positive, 15%–20% were positive for the neuronal marker
MAP2 and the remaining cells were undifferentiated, as revealed by nestin labelling, in agreement
with previous results from our laboratory [8]. When cells were cultured for three days in the presence
of either FBS differentiation medium or BMP4 differentiation medium, labelling for GFAP was about
50% and 70% respectively, thus mainly inducing astrocytic differentiation.
We compared EV secretion in the medium of NSPCs in proliferating conditions (+EGF+bFGF)
and in differentiated NSPCs using three methods to induce cell differentiation, i.e., 10 ng/mL bFGF
(bFGF EVs), 5% FBS (FBS EVs) or 20 ng/mL BMP4 (BMP4-EVs). Results are shown in Figure 2.
Int. J. Mol. Sci. 2019, 20, x 3 of 10 
 
Bovine Serum (FBS differentiation medium); c) cultured in the presence of 20 ng/mL Bone 
Morphogenetic Protein 4 (BMP4 differentiation medium) [24]. In the last two culture conditions, 
enrichment in astroglial cells was achieved. We decided to also use BMP4 as a differentiating agent 
because, as specified in Section 2.2, its use may prevent the possibility that, even after FBS 
ultracentrifugation (see Section 4.2), exosomes still present in FBS may have influenced our results. 
SP s, aintained in the presence of bF F differentiation ediu , differentiated into cells 
exhibiting an astrocytic and neuronal phenotype, as de onstrated by anti- lial Fibrillary cidic 
Protein ( F P) and anti- icrotubule ssociated Protein ( P2) labelling. In particular, after three 
days in culture, 30 –35  cells ere F P-positive, 15 –20  ere positive for the neuronal arker 
2 an  the re aining cells ere n ifferentiate , as reveale  by nestin labelling, in agree ent 
ith previous results from our laboratory [8]. When cells were cultured for three days in the 
presence of either FBS differentiation medium or BMP4 differentiation medium, labelling for GFAP 
was about 50% and 70% respectively, thus mainly inducing astrocytic differentiation. 
e co are   secretion in the ediu  of NSPCs in proliferating conditions (+ F+bF F) 
an  in ifferentiate  S s sing three etho s to in ce cell ifferentiation, i.e., 10 ng/  bF F 
(bF F s), 5  F S (F S s) or 20 ng/  4 ( 4- s). es lts are sho n in Fig re 2. 
 
Figure 2. EV secretion by NSPCs maintained under different culture conditions for three days. 
Proliferating cells were cultured under proliferating conditions (+EGF+bFGF) and in differentiated 
conditions in the presence of bFGF or FBS or BMP4. Furthermore, cells were maintained for three 
days with BMP4 and then for two additional days in the absence of BMP4 (BMP4-depleted). Values 
are the mean of at least three independent experiments. Statistical analysis was performed by using 
an ANOVA test with multiple comparison. * p < 0.05; ** p < 0.01. 
As shown, cells obtained by astrocytic differentiation released a much higher amount of EVs in 
extracellular space compared to proliferating cells or differentiated cells obtained omitting EGF. To 
exclude the effect due to the possible contamination of differentiating factors in the medium of EV 
collection, we determined the amount of EV released from NSPCs differentiated in the presence of 
BMP4 for three days and then maintained the cells for two more days in a basal medium. The EVs 
were collected from the medium of the last two days and referred to as BMP4-depleted EVs. We 
conclude that cells obtained in the two conditions of astrocytic differentiation released the same 
amount of EVs and that the amount of EVs was not significantly different, depleting the medium 
from differentiating agent BMP4 (BMP4 EVS versus BMP4-depleted EVs is not significant, with P = 
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Figure 2. EV secretion by NSPCs maintained under different culture conditions for three days.
Proliferating cells were cultured under proliferating conditions (+EGF+bFGF) and in differentiated
conditions in the presence of bFGF or FBS or BMP4. Furthermore, cells were maintained for three days
with BMP4 and then for two additional days in the absence of BMP4 (BMP4-depleted). Values are
the mean of at least three independent experiments. Statistical analysis was performed by using an
ANOVA test with multiple comparison. * p < 0.05; ** p < 0.01.
As shown, cells obtained by astrocytic differentiation released a much higher amount of EVs
in extracellular space compared to proliferating cells or differentiated cells obtained omitting EGF.
To ex lude the eff ct due to the possibl contamination o differentiating factors in the medium of EV
collection, we de ermined the amount f EV released rom NSPCs differentiated in the presence of
BMP4 f r thr e days and then maintai ed the cells for two ore day in a basal m ium. The EVs were
collected from the medium of the last two days and referred to as BMP4-depleted EVs. We conclude
that cells obtained in two conditions of astrocytic differentiation released the same amount of EVs
and that the mount of EVs was not significa tly different, depleting th medium f om differentiating
gent BMP4 (BMP4 EVS versus BMP4-depleted EVs is not significant, with P = 0.371). Western blot
analysis with exosom l markers showed no differences between EVs secreted by proliferati g cells and
by cells differe tiated under the conditi ns describ d in Figure 2.
2.2. FBS and BMP4 EVs Enhance Differentiation of Proliferating NSPCs
NSPCs were maintained for three days in Expansion Medium (+bFGF+EGF) and daily
supplemented with fresh EV preparations obt ined from NSPCs differentiated with FBS differentiation
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medium. This preparation was called FBS EVs. We used two different concentrations of EVs (7.5 and
15 µg/mL) to assess a dose-dependent effect on these cells due to the EVs. EV concentrations were
chosen on the basis of previous observations described in the literature [18,19,25]. After three days of
incubation, cells were stained with anti-GFAP, anti-MAP2 and anti-nestin antibodies (Figure 3).
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Figure 3. SPCs maintained in medium containing +EGF+bFGF and treated or untreated with 5% FBS
EVs at 7.5 and 15 µg/mL. (A) Bright-field images of cultures; (B) immunofluorescence labelling with
anti-GFAP (green) and anti-nestin (red) antibodies and DAPI (blue); (C) quantification of GFAP-, nestin-
and MAP2-positive cells after three-day treatment with 5% FBS EVs (7.5 and 15 µg/mL) compared to
untreated controls (+EGF+bFGF). Scale bar: 100 µm (images in A and B have the same magnification).
Values are mean of at least three independent experiments. * p < 0.05; *** p < 0.0001.
Astroglial-like morphology was developed by cells upon treatment with EVs but it was not
exhibited by untreated cells. Percentage of immunostained cells for GFAP was increased, with
GFAP-positive cells reaching 18.13% ± 5.11% after EV treatment compared to nontreated NSPCs,
with a parallel decrease of nestin expression. No changes in MAP2 staining were observed between
treated and untreated NSPCs. Furthermore, we observed that differentiation could depend on EV
concentration in the medium. In cells treated with double the concentration of EVs, we observed a
higher increase of GFAP-positive cells (34 ± 3.75%) compared to nontreated cells (4.47 ± 0.82%), with a
significant additional reduction of nestin-positive cells (from 87.97 ± 0.64% to 68.48 ± 3.47%). In this
case, differences in MAP2 staining were also not observed.
Although the centrifugation procedures described in the Materials and Methods section was
adopted to avoid the presence of vesicles present in bovine serum [26], residual contamination of
morphogenetic or differentiating agents was still possible, so we used the BMP4 differentiation medium
to prepare EVs from astrocyte-enriched cultures [24].
Upon BMP4 treatment for three days, the number of cells expressing GFAP increased by up to 70%,
giving rise to a higher number of differentiated astrocytes that could produce a more homogeneous
EVs population compared with that produced by FBS-differentiated cells.
The treatment of proliferating NSPCs with BMP4 EVs yielded several astrocytes significantly
higher than the control cultures and the double concentration produced a significant increase of
astrocytes with respect to both controls and to the lower EV concentration (Figure 4A–C).
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anti- FAP (red) and anti-nestin (green) antibodies and DAPI (blue); (C) quantification of GFAP-, nestin-
and MAP2-positive cells, incubated for 72 h with BMP4 EVs (7.5 and 15 µg/mL), obtained from cells
treated for three days with BMP4, compared to untreated controls (+EGF+bFGF); (D) quantification of
GFAP-, nestin- and MAP2-positive cells, incubated for 72 h with EVs (15 µg/mL) obtained from cells,
first treated for three days with BMP4 and then for two additional days without BMP4 (BMP4-depleted),
compared to untreated controls (+EGF+bFGF). Scale bar: 100 µm (images in A and B have the same
magnification). Values are the mean of at least three independent experiments. * p < 0.05; *** p < 0.0001.
EVs collected during BMP4 treatment could themselves contain some BMP4 trapped during EV
formation, which could itself in turn, induce a differentiating effect on EV-treated cells. Therefore, we
treated NSPCs for three days with BMP4, then removed the medium containing BMP4 and collected
and used the EVs secreted in the following 48 h in a BMP4-free medium (BMP4-depleted EVs). In this
latter case, there was also significant increase in GFAP-positive cells (20.04 ± 4.21%) with respect to
controls (4.06 ± 0.81%) and a decrease in nestin-positive undifferentiated cells (Figure 4D).
In all experiments carried out with BMP4 EVs, MAP2-positive cells were always well below 10%
of total cells and there was never any difference between the control and treated cells.
3. Discussion
In this paper, we showed that NSPCs from embryonic mouse spinal cords can release EVs among
which exos mes are present, as demonstrated by the enrichment of well-known exosomal markers
(TSG-101, tetraspanins CD63 and CD81) in our samples. The rate of secretion appears constant for
about 48 h, although exogenous factors, such as time in culture and cell-to-cell contact could have a
significant impact.
Proof that NSPCs-derived EVs play a role in intercellular communication requires that these
vesicles are taken up by NSPCs and that this event can modify the biology of target cells. It has been
demonstrated that exosomes are uptaken in a selective way by neighboring cells and that their uptake
can lead to the activation of cell proliferation and differentiation [10,18,27].
We also demonstrated that EVs produced by differentiated neural progenitor cells can influence
the phenotype of target cells; in particular, they can stimulate differentiation of proliferating NSPCs.
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In addition, we obtained EVs from cells that had been differentiated by two different methods: One
pool of EVs was obtained from NSPCs differentiated with 5% FBS (FBS EVs) and the other was
produced by NSPCs cultured in the presence of BMP4 (BMP4 EVs); under both these culture conditions,
NSPCs differentiated in a highly enriched astrocyte population. Proliferating NSPCs, treated with the
EV pools produced in these two ways, showed an induction of differentiation toward an astrocytic
lineage. Treatment with FBS EVs gave rise to approximately 40% astrocytes, while the remaining cells
were still undifferentiated. Using BMP4 EVs, the yield in astrocytes was higher than controls, with a
significant reduction of undifferentiated nestin-positive cells. We also showed that this induction was
not dependent on the presence of morphogen BMP4 into the harvested EVs population by using EVs
that were from NSPCs differentiated for three days with BMP4 and then maintained for two additional
days in the absence of the differentiating agent (BMP4-depleted EVs), after which period EV harvesting
took place.
In our experiments, EV treatment seemed to stimulate cells to differentiate, addressing target
cells toward an astrocytic phenotype. In the literature, an opposite effect has recently been described,
where exosomes produced by C6 glioma cells instead stimulated cell proliferation when incubated
with primary cultures of rat cortical astrocytes [25]. The reason for such an opposite effect may reside
in the cells of origin of the exosomes: It is likely that C6 glioma cells, being a tumor, may stimulate
proliferation in order to increase the number of cells that invade the tissue. It is in fact well established
that, together with some general markers that are common to all exosomes regardless of their source,
many of the proteins and miRNAs transported by exosomes reflect the nature of their cells of origin.
The original result of this paper is that EVs produced and secreted by normal differentiated
embryonic progenitor neural cells may activate the differentiation of normal NSPCs toward a specific
phenotype, thus having a potential role in the process that takes place in the neural progenitor cell
niche. The results shown in all previous papers reporting similar effects were obtained with exosomes
produced either by tumor cells or by cell lines. Our data also suggest that EVs secreted by committed
cells can induce or trigger the differentiation of proliferating cells. Furthermore, it is very interesting
and worth further investigation that, when NSPCs were treated with EVs obtained from a mixed
population of neuronal and glial cells, their differentiation always took place toward an astrocytic
phenotype. EVs could contribute to the observed induction toward an astrocytic lineage, possibly by
embedding miRNAs that were able to reprogram multiple cellular mechanisms in recipient cells.
Recently, it has been demonstrated that astrocytes and their exosomes share numerous miRNAs
but some of them are uniquely expressed in exosomes [28]. It was also proven that vesicles released by
cells could reflect the characteristics of their cells of origin (reviewed in [9]). These specific miRNAs
present in exosomes probably control some differentiative targets in the recipient cells. In our model, it
would be interesting to analyze the vesicular content of FBS or BMP4 EVs in order to clarify their role
in the astrocytes’ differentiation induction.
This study demonstrates that EVs from astrocyte-like cells can steer NSPC differentiation toward the
glial lineage. We propose that, in addition to contact-dependent signals requiring cell-to-cell connection
and the secretion of soluble factors such as cytokines and neurotransmitters from differentiated cells,
communication through EVs can also provide the signals required for the activation of the gliogenic
process, thereby contributing to the temporarily regulated transition from the neurogenic to the
gliogenic phase during development. In the future, it is important to assess whether EV preparations
from different neural cell types (e.g., neurons vs. astrocytes) can differently modulate NSPC properties
and whether such mechanisms also occur in vivo.
4. Materials and Methods
4.1. NSPC Cultures
All animal-related procedures were carried out following the European Communities Council
Directive No. 86/609/EEC (November 24, 1986). Animals were anesthetized and sacrificed by decapitation.
Int. J. Mol. Sci. 2019, 20, 3691 7 of 10
NSPCs were obtained from E13.5 mouse embryonic spinal cord and adapted to cell cultures
as previously described [8,29,30]. Cells were maintained in a medium referred to as the “Expansion
Medium” consisting of basal medium (Dulbecco’s Modified Eagle’s Medium (DMEM)/F12,
1% penicillin/streptomycin, 0.1 M L-glutamine (Sigma-Aldrich, St. Louis, MO, USA), 23.8 mg/100 mL
Hepes, 7.5% NaHCO3, 0.6% glucose), supplemented with 20 ng/mL human recombinant EGF (EGF; R
and D Systems, Minneapolis, MN, USA), 10 ng/mL of basic fibroblast growth factor (bFGF; Peprotec,
London, UK) and 1% N2 supplement. NSPCs were routinely expanded in T25 flasks (Corning, Corning,
NY, USA), coated with 10µg/mL polyornithine and 5µg/mL laminin (Sigma-Aldrich) and cultured at
37 ◦C in a 5% CO2 atmosphere. Cells were passaged every 3–5 days using Accutase (Sigma-Aldrich)
and usually seeded at a density of 10,000–15,000 cells/cm2.
4.2. Differentiation Conditions
For astrocyte differentiation, NSPCs were plated in Expansion Medium (6000 cells/cm2 in
T75-coated flasks) and 24 h later the medium was replaced with basal medium containing 1% N2,
2% B27 and 20 ng/mL BMP4 (Peprotech) or 5% FBS (Sigma-Aldrich) and termed differentiating media.
To eliminate the risk of adding EVs possibly present in bovine serum, FBS was routinely centrifuged
overnight at 100,000 g before use [26].
After 3 days in the presence of BMP4, NSPCs differentiated into a highly enriched astrocyte
culture (70%–80%); after 3 days of FBS, NSPCs differentiated into a mixed culture of glial cells (about
50%) and residual progenitor cells.
Mixed cultures of neurons and glial cells were obtained omitting EGF from the expansion medium,
termed bFGF differentiation medium [31].
4.3. Immunocytochemistry
Cells were plated on glass coverslips coated with polyornithine/-laminin. At the appropriate time
points, after fixation with 4% paraformaldehyde (PFA, Sigma-Aldrich) in PBS for 20 min, cultures
were washed with PBS, pH 7.4 and incubated in PBS containing 5% of the appropriate normal serum
and 0.025% Triton X-100 (blocking solution) for 45 min at room temperature. Primary antibodies
(monoclonal anti-nestin, Millipore, Burlington, MA, USA) MAB533 1:1000; polyclonal anti-MAP2
Millipore AB5622 1:300; polyclonal anti-GFAP, Dako Z0334 1:500) were then applied and incubated
overnight at 4 ◦C. Cells were then washed 3 times with PBS and incubated for 2 h at room temperature
in a solution containing 10 µg/mL Hoechst 33342 and the appropriate secondary antibodies, FITC- or
Cy3-conjugated (Jackson Immuno-Research, West Grove, PA, USA) at a dilution of 1:300. After rinsing
with PBS, cells were coverslipped with a DAKO mounting medium (Dako, Carpinteria, CA, USA).
Immunostaining specificity was assessed by omitting primary antibodies. For each experiment,
9 random fields for each coverslip were examined and 3 or more independent experiments were
analyzed. Immunofluorescence was observed using a Nikon Eclipse TE300 microscope. Nine random
fields from each coverslip were photographed with a Nikon DS-U3 digital camera and counted.
Nuclear DNA was counterstained with Hoechst 33342. At least 400 cells per experiment were counted
and each experiment was repeated from 3 or more separate cultures. Results are expressed as
mean ± SEM.
4.4. Isolation of EVs
Extracellular vesicles were isolated from the NSPC culture medium by sequential
ultracentrifugation. Cells were plated at 6000 cells/cm2 in 3 T75-coated flasks in expansion medium
and 24 h later the medium was replaced with an EV-harvesting medium (basal medium supplemented
with 1% Invitrogen supplement (ITS), 5% EV-depleted FBS or 20 ng/mL BMP4). Then, 15 mL of
EV-harvesting medium was added to flasks every 36 h, collecting a final volume of 45 mL after 3 days of
NSPC differentiation. The medium was subjected to sequential centrifugation and ultracentrifugation
(20,000 g for 20 min, 10,000 g for 30 min and 100,000 g for 4 h at 4 ◦C by using a Sorvall SW40 centrifuge
Int. J. Mol. Sci. 2019, 20, 3691 8 of 10
(Thermo Fisher). The obtained EV pellet was resuspended in 1:700 of its initial volume [32] in phosphate
buffered saline (PBS) or sample buffer (without beta-mercaptoethanol). Protein concentration was
determined by Lowry assay and equal amounts of protein samples were subjected to SDS-PAGE,
followed by immunoblotting.
4.5. Western Blot Characterization of EVs
To obtain whole-cell extracts, NSPCs were harvested in a RIPA buffer (320 mM sucrose,
50 mM TRIS pH 7.5, 1% Triton X-100, 10% glycerol) and 1% of inhibitor of proteases cocktail
(Sigma-Aldrich), incubated on ice for 30 min and centrifuged for 12 min at 13,000 g. Protein amount
was quantified by Bradford assay (BioRad, Hercules, CA, USA) and 10–20 µg of protein was subjected
to SDS-polyacrylamide gel electrophoresis and transferred overnight onto a polyvinylidene difluoride
membrane (Immobilon-PSQ, Millipore). Membranes were blocked in 5% nonfat dry milk and then
incubated with the following primary antibodies: rabbit anti-HSP90 (1:300, Santa Cruz Biotechnology,
Dallas, TX, USA), mouse anti-TSG101 (1:200, Santa Cruz Biotechnology, Dallas, TX, USA), goat
anti-CD63 (1:1000, BD Biosciences, San Jose, CA, USA), mouse anti-CD81 (1:500, BD Biosciences, San
Jose, CA, USA). Blots were washed, incubated with the appropriate horseradish peroxidase-conjugated
secondary antibodies (1:10,000, Jackson Immunoresearch, West Grove, PA, USA), then washed again
and finally incubated in lumilight-enhanced chemiluminescence substrate (BioRad) and exposed to
Chemidoc (BioRad). Densitometric analysis on scanned blots was performed using the ImageLab
program (BioRad).
4.6. Statistical Analysis
Comparisons were performed using Student’s t-test or ANOVA test with multiple comparison.
Data are the average of 3 or more independent experiments and are presented as mean ± SEM.
Differences are considered significant at p < 0.05.
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Abbreviations
NSPCs Neural Stem Progenitor Cells
EGF Epidermal Growth Factor
bFGF basic Fibroblast Growth Factor
BMP4 Bone Morphogenetic Protein 4
GFAP Glial Fibrillary Acidic Protein
MAP2 Microtubule Associated Protein
DMEM Dulbecco’s Modified Eagle’s Medium
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